Two studies find Gulf War veterans have increased risk of ALS

September 22, 2003

ST. PAUL, MN - New research finds that veterans of the 1991 Gulf War have developed ALS (amyotrophic lateral sclerosis) at approximately twice the rate of the general population, according to two studies in the September 23 issue of Neurology, the scientific journal of the American Academy of Neurology. An editorial in the same issue questions the validity of the results.

The studies used different methods yet arrived at similar results.

One study sought to identify all occurrences of ALS in the military after the start of the Gulf War, and found that those deployed to Southwest Asia (Saudi Arabia, Kuwait and other Arab Emirates, Turkey, or on the Red Sea) experienced almost twice the risk of ALS than those who were not deployed. Out of nearly 2.5 million military personnel, researchers verified 107 cases of ALS (40 deployed and 67 non-deployed). The total deployed population (696,118) was less than half the total non-deployed population (1,786,215).

"This study addressed the question, 'Is there a problem with excessive occurrence of ALS among Gulf War veterans?'," said lead study author Ronnie D. Horner, PhD, of the National Institute of Neurological Disorders and Stroke. "We found the answer to be yes."

Among deployed military, Army and Air Force personnel appeared to have a significantly higher risk than the other service branches, but all branches had an elevated risk. As a cross-check of the findings, the data were also evaluated under numerous "what-if" scenarios. The consistency of the findings gave the investigators the confidence to conclude that veterans of the 1991 Gulf War have a higher than expected risk of ALS, according to Horner.

The second study concentrated on age and found that the rate of ALS in young Gulf War veterans was more than two times greater than in the general population. Out of approximately 690,000 Gulf War veterans, 20 ALS cases were confirmed, 17 of whom were diagnosed before age 45. All of the cases had sporadic (non-familial) ALS.

"This study focused on people aged 45 or younger because there aren't enough people over 45 who served in the Gulf War and have ALS," said study author Robert W. Haley, MD, of the University of Texas Southwestern Medical Center at Dallas. "ALS is extremely rare in young age groups. Our findings suggest that some environmental exposure that these veterans had in the Gulf War greatly accelerated the ALS process so that it occurred at a much younger age."

Using national death rates, the study also determined that the rates of ALS in younger age groups remained otherwise stable during the 1990s. Thirteen of the 17 cases younger than 45 were diagnosed in the second half of the eight-year study period. This suggests that it took about four years for symptoms of ALS to start appearing, which would explain why the epidemic curve rose at the end, Haley said.

Both studies noted that further research should be done to identify environmental risks and other factors that could explain the elevated risk of ALS in Gulf War veterans.

An editorial in the same issue of Neurology cautions against uncritical acceptance of these results.

"While a twofold increase in risk may seem impressive, one needs to realize that this is based upon just a small number of cases," said editorial author Michael R. Rose, MD, of King's College Hospital in London. "Therefore the calculated risk may easily be changed either way if the methodology has any flaws."

Unfortunately Gulf War veterans are too small a cluster for reliably studying possible environmental triggers for ALS, according to Rose. The studies' subjects were in different branches of the armed service, deployed in different parts of the Gulf and possibly exposed - or not exposed - to several environmental triggers for illness, including ALS, which makes an accurate search for possible triggers very difficult.

Also known as Lou Gehrig's disease, ALS involves the degeneration of motor neurons which causes muscles to waste away. Approximately 20,000 Americans have ALS, which is usually fatal within five years after diagnosis. The Department of Veterans Affairs added ALS to the list of service-related disabilities in 2001.
The study by Horner et al was funded by the Department of Defense and the Department of Veterans Affairs. The study by Haley was supported by a grant from the Perot Foundation.

The American Academy of Neurology, an association of more than 18,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as stroke, Alzheimer's disease, epilepsy, Parkinson's disease, autism and multiple sclerosis.

For more information about the American Academy of Neurology, visit its web site at

American Academy of Neurology

Related Neurology Articles from Brightsurf:

Lancet Neurology publishes results of AFFiRiS' Phase 1 trial with PD01A in Parkinson's
AFFiRiS AG, a clinical-stage biotechnology company developing novel disease-modifying specific active immunotherapies (SAITs), today announced that detailed results of the phase 1 clinical program with its lead candidate PD01 in early Parkinson's disease (PD) patients were published in the peer-reviewed journal The Lancet Neurology

Telemedicine effective for monitoring patients in large pediatric neurology network
As the COVID-19 pandemic sent entire communities into lockdown, doctors quickly adopted telehealth strategies without knowing whether they would be effective or feasible.

The Lancet Neurology: Discovery could speed diagnosis and treatment of children with life-threatening neurological diseases
A group of life-threatening neurological conditions affecting children have been linked to an antibody which points to potential treatment, according to an observational multicentre study involving 535 children with central nervous system (CNS) demyelinating disorders and encephalitis, published in The Lancet Neurology journal.

Meaningful change in culture urged to save neurology, reduce gender gap
UC Davis School of Medicine dean, NINDS deputy director lead national charge to improve conditions for women in neurology.

BrainStorm Cell Tx publishes NurOwn ALS Phase 2 randomized trial data in neurology
Results from Brainstorm Cell Therapeutic's NurOwn randomized Phase 2 clinical trial were published in Neurology.

The Lancet Neurology: Pioneering study suggests that an exoskeleton for tetraplegia could be feasible
A whole-body exoskeleton, operated by recording and decoding brain signals, has helped a tetraplegic patient to move all four of his paralysed limbs, according to results of a 2-year trial published in The Lancet Neurology journal.

The Lancet Neurology: Frailty could make people more susceptible to dementia
New research published in The Lancet Neurology journal suggests that frailty makes older adults more susceptible to Alzheimer's dementia, and moderates the effects of dementia-related brain changes on dementia symptoms.

The Lancet Neurology: Cannabis-based drug in combination with other anti-spasticity
Oral spray containing two compounds derived from the cannabis plant reduced spasticity compared with placebo in patients already taking anti-spasticity drugs.

New neurology studies a 'wakeup call' for global health
Neurology experts from around the world will convene Nov. 27 in New Zealand for a Global Brain Summit examining what one calls 'the greatest challenge of societies in the 21st century.' Among the neurological disorders to be discussed at the Summit are stroke, traumatic brain injury, Alzheimer's disease, Parkinson's disease, multiple sclerosis, and migraine and other headaches.

The Lancet Neurology: Daily and weekly cycles of epileptic seizures more common than previously thought
Understanding the pattern of seizures, and how they are linked to circadian rhythms, could be important in improving management of epilepsy.

Read More: Neurology News and Neurology Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to